Nitric oxide causes inactivation of the low molecular weight phosphotyrosine protein phosphatase. by Caselli, Anna et al.
THE JOURNAL OF BIOLOGICAL HEMISTRY 
0 1994 by The American Society for Biochemistry and Molecular Biology, Inc. 
Vol. 269, No. 40, Issue of October 7, pp. 24878-24882,  1994 
Printed in U.S.A. 
Nitric  Oxide  Causes  Inactivation of the Low Molecular  Weight 
Phosphotyrosine  Protein  Phosphatase* 
(Received for publication, April 18, 1994, and  in revised form, June 22, 1994) 
Anna  CaselliS,  Guido  CamiciS,  Giampaolo ManaoS, Gloriano Monetig, Luigia PazzagliS, 
Gianni Cappugi$, and Giampietro RamponiSTi 
From the mipartimento  di Scienze Biochimiche, Universita di  Firenze, Viale Morgagni 50, 50134 Firenze, Italy  and the 
SDipartimento di  Farmacologia  Preclinica  e Clinica, Universita di  Firenze, 50134 Firenze, Italy 
The low M, phosphotyrosine protein phosphatase 
(PTPase)  and Yersinia enterocolitica PTPase  are inacti- 
vated  by nitric oxide-generating compounds.  Inorganic 
phosphate, a competitive inhibitor, protects the en- 
zymes  from inactivation, suggesting that the action of 
NO is directed to the active sites. Low M, PTPase  from 
bovine liver lost two  out of eight thiol  groups  present  in 
the  molecule  during the inactivation  with  sodium nitro- 
prusside  and  with  other  NO-producing  compounds.  The 
mass  spectrometric analyses of tryptic  fragments of the 
enzyme,  performed after chemical  modification of the 
NO-unreacted  thiol  groups,  demonstrated  that NO 
caused the oxidation  of  Cys-12  and  Cys-17 to form an S-S 
bond. A similar reaction was  described  previously  for 
the reaction of NO with h”methyh-aspartate receptor. 
The NO-inactivated  low M, PTPase  was  reactivated by 
treating the inactive enzyme  with  thiol-containing re- 
agents. Since all members  of the PTPase  family have the 
same  reaction  mechanism  and possess a  conserved ac- 
tive site motif  that contains an essential cysteine resi- 
due, the findings  on  low M, and Yersinia PTPases  are 
potentially interesting for  all  PTPases,  an  enzyme class 
that is involved in a number of important biological 
processes. 
Low M, phosphotyrosine  protein  phosphatase  (PTPase)’ (EC 
3.1.3.48) is  a cytosolic enzyme that was previously  known as 
low M, acid  phosphatase. The enzyme  from  bovine liver was 
sequenced in our  laboratory (1). Although  the  enzyme has no 
general structural homology with the  PTPase  family  enzymes 
(a  large  family that includes  both  receptor-type  (such as leuco- 
cyte common antigen PTPase and leucocyte antigen-related 
PTPase) and soluble  enzymes  (such as human placenta PTPlB, 
and  rat brain PTPl), we recently  demonstrated that an active 
site  motif, CxxxxxR, is common to low M ,  and other PTPases 
(2). In addition,  both low M, PTPase and all  members of the  
PTPase family  have the same reaction  mechanism.  They  form 
covalent thiol-phosphate intermediates during the catalytic 
process (2, 3). Isoenzyme  pairs,  produced  through  alternative 
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tein phosphatase; PTP1, rat brain PTPase; AcPl andAcP2, rat liver low 
The abbreviations used are: PTPase, low M, phosphotyrosine pro- 
M, PTPase isoenzymes; SIN-l,3-morpholinosydnonimine; SNP,  sodium 
nitroprusside; SNC, S-nitrosocysteine; CF-FAB, continuous flow fast 
atom bombardment; ODTB, 5-(octyldithio)-2-nitrobenzoate; HPLC, 
high  performance  liquid  chromatography. 
splicing of a single gene were isolated  from  both  human eryth- 
rocytes and rat liver  and then sequenced (4-6). They differ in  
the sole 40-73 stretch that is  isoenzyme-specific. 
Nitric oxide produced in biological systems has been impli- 
cated in a number of physiological  processes that include 
smooth  muscle  relaxation, inhibition of platelet  aggregation, 
neurotransmission,  immune  regulation,  and  penile  erection  (7, 
8). Furthermore, the S-nitrosylation of proteins  caused  by NO 
was demonstrated (9-13). The  reaction  proceeds  easily in phys- 
iological conditions. Taking into  account that the low M, 
PTPase  contains  two  very  reactive  thiol  groups,  which are lo- 
cated in the  active  site (l), we began to  study  the  effect of nitric 
oxide  on this enzyme. 
MATERIALS AND METHODS 
All unspecified reagents were the  purest commercially available. So- 
dium nitroprusside was  from  Sigma; SIN-l was a generous gift from 
Cassella-AG, Frankfurt, Germany. S-nitrosocysteine was prepared as 
described by  Lei et aZ. (111, and ODTB was from Fluka. Rat liver AcPl 
and AcP2 isoenzymes and bovine liver PTPase were prepared as de- 
scribed  previously  (1,  6); recombinant PTPase from  Yersinia enteroco- 
Zitica (34 kDa fragment) was purchased from  Boehringer Mannheim. 
HPLC  column  (Vydac protein and peptide C,,-column  (4.6 x 250 mmN 
was purchased from  Vydac. 
Enzyme  Assay-The enzyme activity was determined using p-nitro- 
phenyl phosphate (4 nm final concentration) in 0.1 M sodium acetate 
buffer, pH 5.5, containing 1 mM EDTA. Incubation was  performed at 
37 “C. The reaction was stopped with 0.1 M KOH, and the released 
p-nitrophenolate ion  was measured at 400 nm ( E  = 18,000 M - ~  cm-I). The 
unit of enzyme activity is defined as the amount of enzyme that cata- 
lyzes the hydrolysis of one pmol  of p-nitrophenyl phosphate/min. 
Inactivation ofPTPases with NO-producing Compounds-The  low M ,  
PTPase (0.1 nmol)  was equilibrated with 0.05 M 3,3-dimethylglutarate 
buffer,  pH 7.0, by repeated concentration-dilution cycles using Centri- 
con-10 microconcentrators (Amicon,  Inc.). Then, it was transferred into 
a 0.3-ml  Reacti-Vial  equipped with a Mininert valve (Pierce). The vol- 
ume  was adjusted to  0.1 ml with the same buffer, and a nitrogen atmo- 
sphere was created by purging the vial  with nitrogen gas. The valve  was 
closed, and the needle-seal cylindrical septum was inserted in its hole. 
Then, the valve  was  opened, and 10 pl of SNF’, SIN-1, or  SNC solutions 
(freshly prepared) were  added using a microsyringe (through the rubber 
cylindrical septum) to obtain the final desired concentration. The  valve 
was closed, and the mixture was incubated at 25 “C. Aliquots were 
withdrawn (with a microsyringe through the rubber cylindrical septum) 
at  interval times to assay the residual activity. Experiments with SNP 
were  performed under diffused sunlight, since NO production  from SNP 
is directly related to light exposure  conditions  (14). All  of these experi- 
ments, i.e. those performed both in the presence and in the absence of 
Pi (a competitive inhibitor) as well as in the controls without SNP,  were 
carried out contemporaneously  to equilibrate the light exposure. Con- 
trols in the  dark were  also  performed. 
Inactivation Experiments with NO Gas-The low M, PTPase (1 
nmol),  dissolved in 0.05 M 3,3-dimethylglutarate buffer, pH  7.0, was put 
into a small dialysis tube and exposed  to the direct action of authentic 
NO gas bubbled into the dialysate (the same buffer,  located in a cylin- 
drical tube with a 2-cm diameter). Before NO treatment, the enzyme 
solution was  deoxygenated by bubbling highly  purified nitrogen gas in 
the dialysate. A valve that protected the dialysate from the  air was 
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TABLE I 
Inactivation of some PTPases with NO or NO-generating compounds 
All incubation were  performed at  25  "C. The results are mean values of at least  three different determinations. SNP experiments were  performed 
under similar sunlight exposure (14). 
R'Pase form 
Relative activity 
0" 5" 10" 15" 20" 25" 30" 60" 
Bovine (none)b 100  100 100 100 96 95 
Bovine (none)' 100 100 95 
Bovine + 0.25 mM SNP' 43 16 
Bovine + 0.50 m~ SNPb 26 1.1 
Bovine + 0.50 mM SNP + 20 mM Pib 86  85 
Bovine + 0.50 m~ SNP' 26  1.0 
Bovine + 0.50 mM SNP (in the dark)* 98 98 97 94 
Bovine + 0.10 rn SNC' 88 72 58 
Bovine + 0.25 mM SNCb 58  46 37 
Bovine + 0.25 rn SNC + 20 mM P,b 100  97 91 
Bovine + 0.25 mM SIN-lb 27 1.5 
Bovine + 0.50 mM SIN-lb 18 0.1 
Bovine + 0.25 mM SIN-1 + 20 mM P,b 88 80 
Bovine + NO gas' 20 1.8 
Bovine + NO gas + 30 mM P: 90 85 
Rat AcPl (none)b 100 100 94 
Rat AcPl + 0.25 mM SNPb 30 14 
Rat AcPl + 0.25 mM SNP + 20 m~ P t  80  67 
Rat AcP2 (none)b 100  96 93 
Rat AcP2 + 0.25 mM SNPb 33 16 
Rat AcP2 + 0.25 mM SNP + 20 mM Piib 93 73 
Yersinia (none)d 100 96  89  80 
Yersinia + 0.50 mM SNPd 30  3.7  0.4 
Yersinia + 0.50 mM SNP + 30 mM P: 94  65  43 
a Incubation times in minutes. 
0.05 M 3.3-dimethvlelutarate buffer.  DH  7.0. _ _  
0.1 M Tks-HCl buffe;, pH 7.5. 
0.02 M Tris-HC1  buffer, pH 7.2, containing 30%  glycerol. 
inserted. In addition, the surface of the enzyme solution in the dialysis 
tube was also maintained under a nitrogen atmosphere during the 
exposure to  NO gas. These experiments were  performed at room tem- 
perature both in  the absence and in the presence of pi.  Aliquots  were 
withdrawn (using a microsyringe through a rubber septum) at interval 
times to assay the activity. 
Determination of Free  Thiol  Groups-Free thiol groups  were titrated 
by  ODTB as described by Faulstich et al. (15). This reagent reacts with 
protein-free thiols faster  than Ellman's reagent; this is probably due to 
its lipophilic  hydrocarbon chain and the absence of one negative charge 
that permits its access to thiol groups that normally remain undetected 
by the Ellman's reagent (15). Free thiols were titrated both  before and 
after about 90% inactivation of the enzyme with SNP and SIN-1. 
Enzymic  Digestions,  HPLC Separation, and Amino  Acid  Analysis- 
Tryptic digestion was carried out as follows. The enzyme  (30  nmol), first 
inactivated and then treated with ODTB, was purified from low M ,  
reagents by repeated concentration-dilution cycles using Centricon-10 
microconcentrators (Amicon, Inc.). The dilution buffer was 0.2 M am- 
monium bicarbonate, pH 8.5. The final volume  was adjusted to  0.15  ml, 
and digestion with trypsin (5%, w/w) was  performed by incubating the 
mixture at 37 "C for 2 h. Then, trypsin (5% (w/w))  was newIy added, and 
the incubation was continued for an additional 14 h. Peptides were 
separated using reverse phase HPLC with a Vydac  C18 column. Amino 
acid analysis was performed after acid  hydrolysis (6 N HC1 at 110  "C  for 
20 h) using a Carlo Erba 3A29 amino  acid analyzer. 
The tryptic hydrolysate was also analyzed using a capillary liquid 
chromatography/CF-FAB system (Kontron Instruments, Milan) with a 
reverse phase Hypersil C18,3 pm, with a column 300 pm, inner diam- 
eter, x 15 cm  (LC Packing, Amsterdam). The mobile phase was water/ 
acetonitrile containing 0.03% trifluoroacetic acid and was run at a flow 
rate of 4 pvmin. 
Mass Spectrometry-Ion spray mass spectra were acquired on a Per- 
kin Elmer Sciex  API 111 mass spectrometer (Sciex Co., Thornhill, On- 
tario, Canada). The ion spray spectrum of the T64 peptide, in positive 
ion  mode, was obtained under the following  conditions:  ion spray volt- 
age, 5.5 kV; orefice voltage, 65 V; scan range miz,  1000-2000; scan rate, 
2.5 mdatomic mass unit; resolution > 1 atomic mass unit. The sample 
was  dissolved in methanol ( l O - p l  loop, Rheodyne). The spectrum was 
acquired in MCA  mode  by summing 10 scans. 
CF-FAB spectra were  performed  on a VG-7070 EQ mass spectrome- 
ter (VG Analytical, Manchester, United Kingdom). Data were acquired 
and processed on a Vector/two system (Teknivent corp., Maryland 
Heights, MO). A laboratory-made CF-FAl3 probe, a pLC-500  microflow 
pump (Kontron, Zurich, Switzerland), and a Rheodyne (Coteti, CA) 
model 7520 injector with a 0.5-pl internal loop were used. The CF-FAB 
matrix (acetonitrile/water, 7525, (v/v), containing 1% saturated aque- 
ous oxalic  acid and 1% 2,2'-dithiodiethanol) was carried into the mass 
spectrometer by a 1 m x 50 pm internal diameter deactivated fused 
silica capillary column at the flow rate of 4 pvmin. An Ion Tech gun 
(Xenon beam operated at 8 keV) was used, and the temperature of the 
probe tip was kept at 35 "C (scan range, mlz, 120-1700; scan rate 10 
s/decade; resolution 1500 (10% valley definition). 
RESULTS 
Inactivation of Low M, and Yersinia enterocolitica PTPases 
by Nitric Oxide-The treatment of  low M, PTPase from bovine 
liver with  the NO-generating compounds SNP, SIN-1, and SNC 
causes concentration- and time-dependent loss of enzyme ac- 
tivity (Table I). In all cases,  when Pi (a competitive inhibitor of 
the enzyme) was added to  the incubation mixtures,  strong  re- 
ductions in  the  inactivation  rates were observed. If the  treat- 
ment with SNP was carried out in the dark, there was no 
appreciable  decrease in enzyme  activity during  the experimen- 
tal time. 
SNP and SIN-1 are well known as chemical NO donors, 
which provide a continuous flux o f  NO (16). SNP releases NO 
spontaneously when exposed to light since a photochemical 
reaction is involved (14). In  the  dark,  SNP does not release NO 
(14). SNC also was previously used  as NO donor (11,121. Thus, 
the experiments presented in Table I demonstrate that  the 
inactivation of  low M, FTPase from bovine liver is due to  the 
action of NO on the enzyme. The direct  action of the  authenctic 
NO gas on the enzyme was tested. Table I also shows that 
authentic NO gas caused a time-dependent loss of enzyme ac- 
tivity and  that Pi protected the enzyme from inactivation. Since 
low M, FTPase is expressed as two different molecular forms in 
tissues  such as human erythrocytes and rat liver (5,6), we also 
performed  a series of experiments with AcPl  and AcP2 rat liver 
isoenzymes in  the presence of SNP. These isoenzymes have 
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common 1-39 and 74-157 sequences, whereas they differ in 
residues 40-73 (6). We found that  the behavior of AcPl  and 
AcP2 is the  same  as  that of bovine liver enzyme. This  suggests 
that NO inactivation does not involve residues  that  are isoen- 
zyme-specific. The  protection of the enzyme from inactivation 
by Pi clearly indicates  that  the NO inactivation  depends on the 
reaction of NO with some active site residues. We previously 
demonstrated  that  the  binding of Pi in the active site of the 
enzyme involves the Cys-17-Arg-18 pair  and  that Cys-12 is the 
residue that causes the nucleophilic attack a t  the substrate 
phosphorus,  producing the covalent cysteinyl-phosphate inter- 
mediate  during  the  catalytic process (2). 
The behavior of the  PTPase from Yersinia enterocolitica in 
the presence of SNP was  also tested. Table I reports  the  results 
obtained by incubating Yersinia PTPase with SNP  under  light 
exposure. It  can be seen that  this  PTPase also  lost its activity 
during incubation with SNP. Pi also  protects this enzyme from 
inactivation. Considering that I.: enterocolitica and all other 
PTPases contain a conserved active site motif CxxxyxR (Cys 
and Arg are  essential residues), we thought  that our findings 
relative to low M ,  PTPases (and Yersinia PTPase) might be 
intrinsic  features of all members of the  PTPase family. 
Reversibility of Low M,  PTPase Inactivation-After inactiva- 
tion with 0.25 mM SNC, bovine liver enzyme was treated with 
5 mM 2-mercaptoethanol and incubated overnight at 4 "C. 
When the enzyme  activity  was then  determined,  about 75%  of 
the  initial activity  was recovered. Similar  results were obtained 
using SNP-inactivated enzyme. These findings demonstrate 
that inactivation of the low M ,  PTPase by NO is a reversible 
process. 
The Target of NO Action on Low M, PTPase-Free thiol 
groups were titrated both before and  after inactivation of bo- 
vine liver low M, PTPase with SNP  and SIN-1. We found that 
only 5.7 (with SNP) and 6.1 (with SIN-1) free thiol groups/ 
enzyme molecule were titrated  after enzyme inactivation, 
whereas  7.8 free thiol groups were titrated  in  the  untreated 
enzyme. Thus,  these  results suggest that 2  cysteine residues 
are involved in the enzyme  inactivation by  NO. 
The following strategy was employed to identify the  site(s) 
implicated in  the enzyme  inactivation. Bovine liver enzyme, 30 
nmol in  0.8 ml of 0.1 M Tris-HC1 buffer, pH 7.5, was treated with 
0.5 mM SNP. The  mixture  was incubated at room temperature 
under a nitrogen atmosphere,  and aliquots were withdrawn to 
follow the decrease in activity. At  90%  inactivation, the  mixture 
was treated with 5 m~ (final  concentration) ODTB. Then, the 
protein  was  purified from low M, reagents by repeated concen- 
tration-dilution cycles using Centricon-10  microconcentrators 
(Amicon, Inc.). During these cycles, the original buffer was 
replaced  with 0.2 M ammonium  bicarbonate buffer, pH 8.5, to 
perform trypsin hydrolysis. 
Fig. 1 reports  the HPLC separation of tryptic peptides.  The 
amino acid analysis of all peptides was performed in order  to 
identify the cysteine-containing peptides. In a number of cases, 
particularly for high M, fragments,  the  N-terminal amino acid 
sequence  was determined  using a Milligen protein sequencer. 
Fragments containing all 8 cysteines of the enzyme molecule 
were  obtained (T42, T44, T51, T54, T64). Peptide T64 includes 
uncleaved peptide bonds that  are  the  target of trypsin. The 
inability of trypsin  to cleave some peptide bonds in the chemi- 
cally modified protein  was likely due to the  hindrance caused 
by the  three  large hydrophobic chains S-S linked to Cys-145, 
Cys-148, and Cys-149 (see below). The  peptides T42, T44, T51, 
and T54 were analyzed  using FAB mass spectrometry, whereas 
T64 was analyzed by electrospray mass spectrometry. Fig. 2 
shows the  mass  spectra of all cysteine-containing  peptides. The 
molecular weights found for peptides T44, T51, and T54 were 
Ac-AEQVTKSVLE'VCLGNICRSPIAEAVFRKLVTDQNISDW 
2 0  4 0  
T42 
IDSGAVSDWNVGRSPNPRSCLRNHGINTAHKARQVTKE 
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FIG. 1. HPLC separation of tryptic peptides from SNP-inacti- 
vated and n-octane-1-thiol-modified low M, PTPase from bovine 
liver (bottom). AVydac protein  and  peptide C18 column, 4.5 x 250 mm, 
was  used.  Solvent  A was 10 mM trifluoroacetic acid in  water,  and  solvent 
B was 10 mM trifluoroacetic acid in acetonitrile.  The flow rate  was 0.8 
mumin. Top, the  amino acid sequence of the enzyme.  The underlined 
sequence indicates  cysteine-containing  peptides that were  selected for 
mass spectrometric  analyses. 
535,792,  and 1615, respectively; the calculated  values of these 
peptides S-S-linked to n-octane-1-thiol are 535.25, 791.44, and 
1614.73, respectively. All of these findings agree with the hy- 
pothesis that each  cysteine has been modified by ODTB. The 
molecular weight found for peptide  T64 is 4518 (the calculated 
value of this peptide with  all  three thiols S-S-linked to n-oc- 
tane-1-thiol is 4518.24), suggesting  that  all 3 cysteines have 
been modified by  ODTB. These results  demonstrate  that 
Cys-62 (contained  in T51), Cys-90 (contained in T56), Cys-109 
(contained in T44), and Cys-145, -148, and -149 (all contained 
in T69) are not involved in  the SNP-inactivation of the low M, 
PTPase since they remained unaltered  during  the enzyme in- 
activation. On the  other  hand,  the M, of 1321 found for T42 
clearly demonstrates  that Cys-12 and Cys-17 were not modified 
by ODTB after enzyme  inactivation  by SNP  (the calculated M, 
for this peptide with  free thiols is 1322.7). The M ,  value found 
for Cys-12-Cys-17-containing peptide (T42) agrees well with 
the hypothesis that  these cysteines are linked  together  with an 
S-S bond. In fact, neither Cys-12 nor Cys-17 was S-nitrosylated 
or in free  thiol  forms. This finding is  similar  to  that described 
for the N-methyla-aspartate receptor, where 2 vicinal cys- 
teines reacted first  with NO to form S-nitrosothiols and  then 
formed an S-S bond (11). Cys-12 and Cys-17 are probably very 
near each  other,  since they  are located in  the active site of the 
enzyme (2). These  results also agree  with  the finding described 
above concerning the protection from NO inactivation given by 
the competitive inhibitor Pi. Additional  experiments  with mi- 
cro-HPLC-FAB were performed. Using this technique, some 
additional low M, peptides that contain  cysteine residues were 
found in  the  tryptic hydrolysate, whereas  the T64-peptide was 
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FIG. 2. Mass spectra of the  cysteine-containing  tryptic pep- 
tides from SNP-inactivated and n-octane-1-thiol-modified low 
Mr PTPase from bovine  liver. The  mass  spectra of the peptides T42, 
T44, T51, and T54 were  acquired by  FAB mass  spectrometry,  whereas 
the peptide T64 was produced through a computer  elaboration of the 
spectrum  acquired by electrospray mass spectrometry. (M+H)+ indicates 
the  protonated  molecular ion. 
not revealed  since its mass  was not in  the  range of  FAB mass 
acquisition spectra.  The obtained results  (not  reported) agree 
well with the findings reported above and confirm the forma- 
tion of an S-S bridge between Cys-12 and Cys-17 during  the 
inactivation of the low M, PTPase caused by nitric oxide-gen- 
erating compounds. 
DISCUSSION 
In  the few last  years, it has been shown that NO is involved 
in several biological processes including those cited in  the  in- 
troduction of this  paper (7-13). In a number of cases, NO pro- 
duces its biological effects through  the  stimulation of soluble 
guanylate cyclase, a heme-containing  enzyme. Furthermore,  in 
the case of immunological activation, NO produced by activated 
macrophages acts as a cytotoxic molecule for invading  intracel- 
lular microorganisms and  tumor cells (17). Recently, various 
authors  have suggested a different  action of NO through its 
direct reaction with protein thiol groups (9-13). There  are a 
number of cases  in which enzymes or receptor  proteins modu- 
late their biological activities through the S-nitrosylation of 
exposed and very reactive cysteine residues. In the case of 
glyceraldehyde-3-phosphate  dehydrogenase (9, lo), the inacti- 
vation of the enzyme by in vivo induction of nitric-oxide syn- 
thase, which is ultimately  due  to  the S-ADP-ribosylation of the 
4 active site cysteines in  the enzyme tetramer,  is preceeded by 
the  S-nitrosylation of these cysteines. Furthermore,  in  the case 
of the  N-methybaspartate receptor ( l l ) ,  two vicinal  thiols in 
the receptor protein were first  S-nitrosylated by NO and  then 
oxidized to  form an S-S bridge. In addition, in  the case of the 
tissue-type plasminogen  activator, S-nitrosylation by  NO 
causes  the  protein  to exhibit new functions (13). Finally, 
Gopalakrishna et al. (12) have recently  reported that protein 
kinase C is reversibly and,  in some cases,  irreversibly  inacti- 
vated by NO-generating substances  as well as by activation of 
nitric-oxide synthase  in cell cultures. They  suggest that  this is 
a new type of regulation of this  important enzyme. 
Our findings demonstrate  that NO causes  the inactivation of 
two members of the  PTPase family. PTPases  are involved in a 
number of biological processes such as the  transmission of mi- 
totic signals at different levels of the mitotic  activation cascade. 
A number of oncogene proteins  are  mutated forms of growth 
factor  receptors and possess unregulated tyrosine  protein  ki- 
nase activity; PTPases counteract their action, and some au- 
thors consider PTPases  as antioncogenes (18,191. Some aspects 
of cell cycle control are  exerted by PTPase, as in  the case of the 
cdc25 gene  product that dephosphorylates ~ 3 4 ' ~ '  and causes 
the  entry of the cell in mitosis. All PTPases  have  the common 
active site motif C x x r w z R  and  the  same reaction  mechanism 
(2).  They form a thiol-phosphate covalent intermediate  during 
the  attack of substrate phosphorus by an  essential cysteine in 
the active  site.  Although the low M, PTPase  was  first  studied  as 
an acid phosphatase, its reaction mechanism is  the  same as 
that of both receptor-like and soluble PTPases  and different 
from that of acid phosphatases (Ref. 2 and this work). Further- 
more, the enzyme possesses the conserved active site motif 
CxxxxxR, common to  all  FTPases,  in  the 12-18 sequences of 
all enzyme forms  sequenced up  to now (20). Recently, bovine 
liver low M ,  PTPase  has been  crystallized by Su et al. (21). The 
x-ray crystallographic analysis performed by the  same  labora- 
tories' produced a crystal  structure  that shows a picture dis- 
playing some active site  features common to those of phospho- 
tyrosine  protein 1B from human placenta. This crystal 
structure, recently  reported by Barford et al. (22), is the  first 
PTPase  structure to  be determined. Low M, PTPase possesses 
specific phosphatase activity against tyrosine-phosphorylated 
proteins (23-27). The overexpression of this  particular  PTPase 
caused a decrease  both in  the growth rate  and  the incorporation 
of radioactive  thymidine in  normal  and  in  transformed  animal 
cells as well as a reduced  ability of transformed cells to grow in 
soft agar (28). In  our opinion, inactivation by NO may be a 
general  feature of PTPase family  members since they  all have 
a very  reactive  cysteine in  the active site. 
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